The diabetic foot: Basic mechanisms of disease

Journal of Bone and Joint Surgery

Volumn 83, Issue 7, 2001, Pages 1084-1096

  Guyton, G P ^a   Saltzman, C L ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; DIABETIC FOOT; DIABETIC NEUROPATHY; MECHANICAL STRESS; NEUROPATHIC JOINT DISEASE; PRIORITY JOURNAL; RISK FACTOR; WOUND HEALING;

EID: 0034912719     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/00004623-200107000-00017     Document Type: Conference Paper

References (134)

1. The Semmes-Weinstein monofilament as a potential predictor of foot ulceration in patients with noninsulin-dependent diabetes
2. Screening techniques to identify people at high risk for diabetic foot ulceration: A prospective multicenter trial
3. Distinctive pathologic findings in proximal diabetic neuropathy (diabetic amyotrophy)
4. Mononeuropathy in diabetes mellitus: A phenomenon easily overlooked
5. Diabetes mellitus presenting with bilateral foot-drop
6. Somatosensory, proprioceptive, and sympathetic activity in human peripheral nerves
7. Microneurographic findings in diabetic polyneuropathy with special reference to sympathetic nerve activity
8. Comparison of distal sympathetic and vagal function in diabetic neuropathy
9. Circumscribed cognitive dysfunction in middle-aged adults with type 2 diabetes
10. Impaired ascendant central pathways conduction in impotent diabetic subjects
11. Cerebral complications of diabetes: Clinical findings and pathogenetic mechanisms
12. Diabetic and hypoglycemic neuropathy
13. The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin-dependent diabetes mellitus
14. Future prevention and treatment of diabetic neuropathy
15. The effects of zenarestat, an aldose reductase inhibitor, on peripheral neuropathy in Zucker diabetic fatty rats
16. Sorbitol and myoinositol levels and morphology of sural nerve in relation to peripheral nerve function and clinical neuropathy in men with diabetic, impaired, and normal glucose tolerance
17. Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking
18. Evidence for glucose-mediated covalent cross-linking of collagen after glycosylation in vitro
19. Glycation products and the pathogenesis of diabetic complications
20. Only limited effects of aminoguanidine treatment on peripheral nerve function, (Na+,K+)-ATPase activity and thrombomodulin expression in streptozotocin-induced diabetic rats
21. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies
22. Autoimmune markers and neurological complications in non-insulin-dependent diabetes mellitus
23. The insenstitive foot (including leprosy)
24. Abnormal foot pressures alone may not cause ulceration
25. Plantar aponeurosis and internal architecture of the ball of the foot
26. Experimental friction blisters
27. Frictional properties of human skin: Relation to age, sex and anatomical region, stratum corneum hydration and transepidermal water loss
28. Forces under the foot
29. Lesser toe deformities
30. Multiple role of peripheral neuropathy in the pathogenesis of the so-called "diabetic foot". Clinical and electromyographical (EMG) study of 42 cases of "mutilating acropathy"
31. The diabetic foot
32. A prospective study of risk factors for diabetic foot ulcer. The seattle diabetic foot study
33. Hand abnormalities are associated with the complications of diabetes in type 2 diabetes
34. Limited joint mobility in childhood diabetes mellitus indicates increased risk for microvascular disease
35. Limited joint mobility is associated with the presence but does not predict the development of microvascular complications in type 1 diabetes
36. Long-term glycemic control influences the onset of limited joint mobility in type 1 diabetes
37. Limited joint mobility in non-insulin-dependent diabetic (NIDDM) patients: Correlation to control of diabetes, atherosclerotic vascular disease, and other diabetic complications
38. Connective tissue and joint disease in diabetes mellitus
39. Stiff hands in long term diabetes
40. Limited joint mobility in diabetes mellitus
41. Limited joint mobility in the diabetic foot: Relationship to neuropathic ulceration
42. Insensitivity, limited joint mobility, and plantar ulcers in patients with diabetes mellitus
43. Relationship of limited joint mobility to abnormal foot pressures and diabetic foot ulceration
44. Subcutaneous Achilles tenotomy in the treatment of perforating ulcer of the foot in leprosy
45. Analysis of risk factors for neuropathic foot ulceration in diabetes mellitus
46. Plantar forefoot ulceration with equinus deformity of the ankle in diabetic patients: The effect of tendo-Achilles lengthening and total contact casting
47. Lengthening of the Achilles tendon in diabetic patients who are at high risk for ulceration of the foot
48. Role of neuropathy and high foot pressures in diabetic foot ulceration
49. The risk of foot ulceration in diabetic patients with high foot pressure: A prospective study
50. Foot bearing pressure in patients with unilateral diabetic foot ulcers
51. Postural instability in diabetic neuropathic patients at risk of foot ulceration
52. Ulceration, unsteadiness, and uncertainty: The biomechanical consequences of diabetes mellitus
53. Neuropathic gait shows only trends towards increased variability of sagittal plane kinematics during treadmill locomotion
54. Differences in the gait characteristics of patients with diabetes and peripheral neuropathy compared with age-matched controls
55. Gait abnormalities in diabetic neuropathy
56. Effect of plantar flexor muscle stiffness on selected gait characteristics
57. Quantitative sudomotor axon reflex test in normal and neuropathic subjects
58. Quantitative sweat test in diabetics with neuropathic foot lesions
59. Autonomic denervation may be a prerequisite of diabetic neuropathic foot ulceration
60. Shear stress abnormalities contribute to endothelial dysfunction in hypertension but not in type II diabetes
61. Possible pathophysiological mechanisms for diabetic angiopathy in type 2 diabetes
62. Endothelial dysfunction in diabetes mellitus
63. Diabetic dyslipidaemia and coronary heart disease: New perspectives
64. Diabetic cutaneous microangiopathy
65. Vascular complications in diabetes mellitus
66. Microvascular function in human diabetes. A physiological perspective
67. Functional microangiopathy in diabetes mellitus
68. Retinal vascular autoregulation in diabetes mellitus
69. Glomerular hyperfiltration in diabetes mellitus
70. Impaired autoregulation of glomerular filtration rate in type 1 (insulin-dependent) diabetic patients with nephropathy
71. Impaired autoregulation of blood flow in subcutaneous tissue of long-term type 1 (insulin-dependent) diabetic patients with microangiopathy: An index of arteriolar dysfunction
72. Hemodynamic factors in the genesis of diabetic microangiopathy
73. Pathogenesis of diabetic microangiopathy. The hemodynamic view
74. Relation of skin capillary pressure in patients with insulin-dependent diabetes mellitus to complications and metabolic control
75. Diabetic neuropathy and the microcirculation
76. Intraglomerular pressure and mesangial stretching stimulate extracellular matrix formation in the rat
77. Local postural venomotor reflexes arising from the limb veins
78. Regulation of the microcirculation
79. Blood flow in the skin of the foot related to posture in diabetes mellitus
80. Effect of postural change and thermoregulatory stress on the capillary microcirculation of the human toe
81. Skin flow the venoarteriolar response and capillary filtration in diabetics. A 3-year follow-up
82. Diabetic neuropathy: A clinical and histological study of the significance of vascular affections
83. The effect of varying ambient oxygen tensions on wound metabolism and collagen synthesis
84. Wound microenvironment
85. Common complications of wound healing. Prevention and management
86. Causes of delayed wound healing and optimization of the patient's condition
87. Clinical management of nonhealing wounds
88. Oxygen free radicals and wound healing
89. Host resistance of infection: Established and emerging concepts
90. Oxygen and wound healing
91. Randomized prospective double-blind trial in healing chronic diabetic foot ulcers. CT-102 activated platelet supernatant, topical versus placebo
92. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers
93. Predictors of transcutaneous oxygen tension in the lower limbs of diabetic subjects
94. Peripheral dissemination of bacteria in contaminated wounds; role of devitalized tissue: Evaluation of therapeutic measures
95. Quantitative microbiology of pressure sores in different stages of healing
96. Wound healing alterations caused by infection
97. Effect of extensive debridement and treatment on the healing of diabetic foot ulcers
98. Wound healing
99. Effects of protein depletion on strength of colonic anastomoses
100. Nutrition, tissue oxygenation, and healing of venous leg ulcers
101. Chronic wounds: Pathophysiologic and experimental considerations
102. Biology of wound healing
103. Studies of wound healing in experimental diabetes mellitus
104. Microvascular anastomoses in diabetes: An experimental study
105. Impaired wound healing in streptozotocin diabetes. Prevention by supplemental vitamin
106. The membrane transport of ascorbic acid
107. Sur quelques arthropathies qui paraissant dépendre d'une lesion du cerveau ou de la moelle épinierè
108. On the nature of neuropathic affections of the joints
109. Neurogenic acceleration of degenerative joint lesions
110. The pathogenesis of Charcot's joint
111. Neuropathic fractures and joint injuries. Pathogenesis and rationale of prevention and treatment
112. Atrophic arthropathy and diabetic neuritis
113. The acute neuropathic arthropathy - A rapid, severely disorganizing form of arthritis
114. Sur quelques maladies osseuses et articulares d'origine vasomotrice et sur leur traitment
115. Sympathetic nerve failure in diabetes
116. Pathogenesis of the neurotrophic joint: Neurotraumatic vs. neurovascular
117. The neuropathic foot in diabetes. Part II: Charcot's neuroarthropathy
118. The neuropathic foot in diabetes. Part I: Blood flow
119. Autonomic neuropathy: Blood flow in the diabetic foot
120. Lower limb arterio-venous shunts, autonomic neuropathy and the diabetic foot
121. Osteopenia, neurological dysfunction, and the development of Charcot neuroarthropathy
122. Neuro-osteoarthropathy (Charcot's joint) in diabetes mellitus following revascularization surgery. Three case reports and a review of the literature
123. Pathological changes in arteries following partial denervation
124. Long-term denervation of vascular smooth muscle causes not only functional but structural change
125. Medical arterial calcification and diabetic neuropathy
126. Demineralization and pathological physiology of the skeleton in paraplegic rats
127. Relationship of the microvascular system to bone resorption and growth in situ
128. Nerves in cortical bone
129. Characterization of beta-adrenergic receptors on rat and human osteoblast-like cells and demonstration that betareceptor agonists can stimulate bone resorption in organ culture
130. Measurement of markers of osteoclast and osteoblast activity in patients with acute and chronic diabetic Charcot neuroarthropathy
131. Microisolated mouse osteoclasts express VIP-1 and PACAP receptors
132. Pituitary adenylyl cyclase-activating polypeptides and vasoactive intestinal peptide inhibit bone resorption by isolated rabbit osteoclasts